FR0012333284
FR0012333284
ABIVAX
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 6.89B EUR | 9.22B EUR | 7.42B EUR | 9.46B EUR |
Enterprise Value | 5.9B EUR | 8.83B EUR | 6.95B EUR | 8.94B EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | -27.22x | -- | -- | -- |
Price to Sales | 1,476.96x | -- | -- | -- |
Price to Book | 17.22x | 25.17x | 17.28x | 20.77x |
EV/Revenue | 1,264.86x | -- | -- | -- |
EV/EBITDA | -20.25x | -- | -- | -- |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -1.83% | -2.14% | -2.41% | -1.35% |